Compass Therapeutics Insider Trades
NASDAQ: CMPXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 5 · $102.75K
- Sales
- 0 · $0
- Shares bought / sold
- 72.50K / 0
- Net activity
- Net buying $102,750
Compass Therapeutics insider activity
Over the last 12 months, Compass Therapeutics insiders reported 13 transactions on SEC Form 4: 5 open-market purchases and 0 sales. Insiders bought $102,750 and sold $0 worth of stock, for net insider buying of $102,750. The most recent filing shows Lerner Neil (Chief Accounting Officer) buying 10,000 shares at $0.59 on Nov 17, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CMPX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
CMPX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 17, 2026 | Lerner NeilChief Accounting Officer | Buy | 10,000 | $5.90K | Form 4 |
| Oct 1, 2026 | Lerner NeilChief Accounting Officer | Buy | 20,000 | $18.40K | Form 4 |
| Sep 24, 2026 | Lerner NeilChief Accounting Officer | Buy | 2,500 | $2.85K | Form 4 |
| Apr 29, 2026 | Lerner NeilChief Accounting Officer | Award | 15,000 | $28.35K | Form 4 |
| Apr 29, 2026 | Anderman JonathanGeneral Counsel | Award | 25,000 | $47.25K | Form 4 |
| Apr 29, 2026 | Anderman JonathanGeneral Counsel | Buy | 25,000 | $47.25K | Form 4 |
| Apr 29, 2026 | Lerner NeilChief Accounting Officer | Buy | 15,000 | $28.35K | Form 4 |
| Feb 8, 2026 | Schuetz Thomas J.CHIEF EXECUTIVE OFFICER | Tax withholding | 36,687 | $239.20K | Form 4 |
| Jan 9, 2026 | Schuetz Thomas J.CHIEF EXECUTIVE OFFICER | Tax withholding | 46,777 | $250.26K | Form 4 |
| Jan 2, 2026 | Anderman JonathanGeneral Counsel | Award | 150,000 | $775.50K | Form 4 |
| Jan 2, 2026 | Lerner NeilChief Accounting Officer | Award | 62,500 | $323.13K | Form 4 |
| Jan 2, 2026 | Shin BarryCFO | Award | 125,000 | $646.25K | Form 4 |
| Jan 2, 2026 | Schuetz Thomas J.CEO | Award | 250,000 | $1.29M | Form 4 |
| Nov 16, 2025 | Schuetz Thomas J.CHIEF EXECUTIVE OFFICER | Tax withholding | 44,025 | $212.64K | Form 4 |
| May 27, 2025 | Schuetz Thomas J.CHIEF EXECUTIVE OFFICER | Buy | 10,000 | $21.10K | Form 4 |
| Apr 9, 2025 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VI LLC & OrbiMed Genesis GP LLCDirector | Sale | 3,571,428 | $5.68M | Form 4 |
| Apr 9, 2025 | GORDON CARL LDirector | Sale | 3,571,428 | $5.68M | Form 4 |
| Apr 7, 2025 | Lerner NeilCHIEF ACCOUNTING OFFICER | Buy | 20,000 | $28.40K | Form 4 |
| Apr 7, 2025 | Anderman JonathanGen Counsel & Corporate Sec | Buy | 20,000 | $30.80K | Form 4 |
| Feb 8, 2025 | Schuetz Thomas J.CEO | Tax withholding | 41,687 | $145.90K | Form 4 |
| Jan 9, 2025 | Schuetz Thomas J.CEO | Tax withholding | 58,054 | $107.98K | Form 4 |
| Dec 9, 2024 | Shin BarryCFO | Award | 400,000 | $660.00K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4